{"id":"hb0017-q4w","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Injection site reactions"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"HB0017 Q4W works by binding to its target protein, which plays a crucial role in the immune response. This binding leads to a decrease in the activity of the immune system, resulting in reduced inflammation and potentially therapeutic effects.","oneSentence":"HB0017 Q4W is a monoclonal antibody targeting a specific protein to modulate the immune system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:47:48.324Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of moderate to severe rheumatoid arthritis"}]},"trialDetails":[{"nctId":"NCT06592274","phase":"PHASE2","title":"A Phase 2 Study of HB0017 in Psoriasis Patients","status":"RECRUITING","sponsor":"Huabo Biopharm Co., Ltd.","startDate":"2024-09-30","conditions":"Psoriasis (PsO)","enrollment":200},{"nctId":"NCT06477237","phase":"PHASE3","title":"Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis","status":"RECRUITING","sponsor":"Huabo Biopharm Co., Ltd.","startDate":"2024-03-01","conditions":"Psoriasis","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"HB0017 Q4W","genericName":"HB0017 Q4W","companyName":"Huabo Biopharm Co., Ltd.","companyId":"huabo-biopharm-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"HB0017 Q4W is a monoclonal antibody targeting a specific protein to modulate the immune system. Used for Treatment of moderate to severe rheumatoid arthritis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}